Levemir

Type: Product
Name: Levemir
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Don’t underestimate the potential of new products

John Ansell shows how much better the products launched a decade ago have performed than expected at the time, and considers the dangers of underestimating commercial potential.In the September 2003 edition of In Vivo , three consultants from Bain & Co ... [Published pharmaphorum - Apr 14 2014]
First reported Apr 06 2014 - Updated Apr 06 2014 - 1 reports

Patient Handout: 7 Tips to Drop Excess Pounds with Diabetes

Losing weight when you have diabetes can be a good news-bad news thing. The good news is that dropping even a few pounds can help reduce your need for diabetes medications.When adults with diabetes lose just seven percent of their body weight (only 14 ... [Published Diabetes in Control - Apr 06 2014]
Entities: Diabetes, Insulin, Metformin
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Why We Need Them

Endocrinologists are in a funny position when it comes to people with diabetes . We spend so much time with our diseases that we don't really need them to manage things on a daily basis, but we can't write our prescriptions on our own.Doctors are trained ... [Published Diabetes Health Magazine - Apr 04 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 1 reports

Patent expiration, stagnant R&D spend seriously affect blockbuster sales of big pharma during 2007-2013

Patent expiration of several blockbusters and limited success in launching new molecules during the last few years are the two critical factors that  impacted the revenues of the top international pharmaceutical companies during the period 2007-2013. ... [Published PharmaBiz - Mar 28 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

Tresiba® and Victoza® Receive Positive Opinions From CHMP for Label Updates Expanding Indications for Use in..

DUAL™ I, which compared the efficacy and safety of IDegLira (a combination of insulin degludec and liraglutide in one pen) versus Tresiba® or Victoza® alone in patients with type 2 diabetes, which was uncontrolled on metformin ± pioglitazone[4].DUAL™ ... [Published ADVFN India - Mar 21 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 1 reports

Novo Nordisk Extends Diabetes Operations

Novo Nordisk ( NVO ) has a strong presence in the diabetes care market with one of the broadest diabetes portfolios in the industry.Recently, Novo Nordisk announced that it will invest $100 million in a new research and development facility in Denmark ... [Published Yahoo! Canada - Mar 19 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 1 reports

Maintaining Weight Loss While Taking Insulin

Q: I may need to start taking insulin, but I've just successfully lost 60 pounds. Will insulin cause me to gain the weight back?A:Yes, it is possible that insulin can cause weight gain, although there are ways that you may be able to prevent it.Let me ... [Published EverydayHealth.com - Mar 18 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 1 reports

Novo Nordisk will build $100m facility in Denmark

Novo Nordisk has said it plans to build a new purification plant at its R&D facility in Bagsvaerd, Denmark, to support its diabetes pipeline.The new pilot facility will expand its ability to make active pharmaceutical ingredients (APIs) for use in its ... [Published PMLive - Mar 14 2014]
First reported Mar 11 2014 - Updated Mar 11 2014 - 1 reports

NOVO NORDISK , SANOFI - Tresiba and Ryzodeg Delayed in the US: Lantus Protected - Reduce

(live-PR.com) - Post complete response letter issued by the USFDA to NOVOB for Tresiba and Ryzodeg, we reduce our PT for NOVOB from DKK 1000 to DKK 950. Considering the US constitutes the biggest long acting insulin market (Lantus-US sales: $4b; Western ... [Published Live-PR.com - Mar 11 2014]
First reported Feb 23 2014 - Updated Feb 23 2014 - 1 reports

Drug Patent Expirations in February 2014

Copyright © thinkBiotech Drug Patent Expirations for February 2014TradenameApplicantGeneric NamePatent NumberPatent Expiration LEVEMIR INNOLET Novo Nordisk Inc insulin detemir recombinant 6,869,930 Feb 2, 2014 LEVEMIR PENFILL Novo Nordisk Inc ... [Published Biotech Blog - Feb 23 2014]
First reported Feb 10 2014 - Updated Feb 10 2014 - 1 reports

Type 2 When to take fast acting insulin

I've had diabetes for around 10 years. I have been on Metformin since the beginning, then Levemir, and the doctor recently added Lyxumia and Apidra, the latter to take before having carbs. I am struggling a bit to know when to take Apidra (e.g. before ... [Published HealthBoards - Feb 10 2014]
Entities: Apidra, Insulin, Levemir, Lyxumia
First reported Feb 03 2014 - Updated Feb 03 2014 - 1 reports

Drug Patent Expirations for February 2 2014

Copyright © thinkBiotech If your reader cannot render the information below, go tohttp://www.DrugPatentWatch.com/innovation to see the latest expirationsbody { font-family:Calibri, tahoma, arial,sans-serif;}table { font-size:12px; font-family:Calibri, ... [Published Biotech Blog - Feb 03 2014]

Quotes

"...in 2008, two more products, Alimta and Tarceva, also became blockbusters."
I've heard diabetics say, "I need these prescriptions to live and diabetes doesn't just go away suddenly. So, why do I need to keep going to see these doctors if all they're there for is to renew my prescription?" Well, we go in to see them for an assortment of other reasons. They are there to ask questions that we maybe haven't considered...
...1 or type 2 diabetes, such as the convenience of insulin delivery, the anxiety associated with injections or the confidence in injection accuracy. "The approval of Levemir FlexTouch can help to address these barriers for those prescribed a long-acting basal insulin, resulting in improved treatment adherence" Schlosser said...

More Content

All (19) | News (13) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
Don’t underestimate the potential of new products [Published pharmaphorum - Apr 14 2014]
Patient Handout: 7 Tips to Drop Excess Pounds w... [Published Diabetes in Control - Apr 06 2014]
Why We Need Them [Published Diabetes Health Magazine - Apr 04 2014]
After Bristol Myers' Bydureon Success, The Next... [Published Seeking Alpha - Apr 02 2014]
Patent expiration, stagnant R&D spend seriously... [Published PharmaBiz - Mar 28 2014]
Tresiba® and Victoza® Receive Positive Opinions... [Published ADVFN India - Mar 21 2014]
Novo Nordisk Extends Diabetes Operations [Published Yahoo! Canada - Mar 19 2014]
Maintaining Weight Loss While Taking Insulin [Published EverydayHealth.com - Mar 18 2014]
Moving Target [Published Diabetes Health Magazine - Mar 16 2014]
Novo Nordisk will build $100m facility in Denmark [Published PMLive - Mar 14 2014]
NOVO NORDISK , SANOFI - Tresiba and Ryzodeg Del... [Published Live-PR.com - Mar 11 2014]
Drug Patent Expirations in February 2014 [Published Biotech Blog - Feb 23 2014]
Type 2 When to take fast acting insulin [Published HealthBoards - Feb 10 2014]
Drug Patent Expirations for February 2 2014 [Published Biotech Blog - Feb 03 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Advertising News - Jan 30 2014]
US FDA approves Novo Nordisk's NovoLog FlexTouc... [Published PharmaBiz - Nov 05 2013]
Novo Nordisk A/S: Delårsrapport for perioden 1.... [Published GlobeNewswire: Acquisitions News - Oct 31 2013]
Novo Nordisk: Financial report for the period 1... [Published GlobeNewswire: Acquisitions News - Oct 31 2013]
Novo Nordisk's FlexTouch insulin pen gets Healt... [Published Pharmaceutical Business Review - Oct 21 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Drug Patent Expirations in February 2014 [Published Biotech Blog - Feb 23 2014]
Copyright © thinkBiotech Drug Patent Expirations for February 2014TradenameApplicantGeneric NamePatent NumberPatent Expiration LEVEMIR INNOLET Novo Nordisk Inc insulin detemir recombinant 6,869,930 Feb 2, 2014 LEVEMIR PENFILL Novo Nordisk Inc ...
Type 2 When to take fast acting insulin [Published HealthBoards - Feb 10 2014]
I've had diabetes for around 10 years. I have been on Metformin since the beginning, then Levemir, and the doctor recently added Lyxumia and Apidra, the latter to take before having carbs. I am struggling a bit to know when to take Apidra (e.g. before ...
Drug Patent Expirations for February 2 2014 [Published Biotech Blog - Feb 03 2014]
Copyright © thinkBiotech If your reader cannot render the information below, go tohttp://www.DrugPatentWatch.com/innovation to see the latest expirationsbody { font-family:Calibri, tahoma, arial,sans-serif;}table { font-size:12px; font-family:Calibri, ...
1

Press Releases

sort by: Date | Relevance
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Advertising News - Jan 30 2014]
Novo Nordisk A/S: Delårsrapport for perioden 1.... [Published GlobeNewswire: Acquisitions News - Oct 31 2013]
Novo Nordisk: Financial report for the period 1... [Published GlobeNewswire: Acquisitions News - Oct 31 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.